Landsem A, Fure H, Krey Ludviksen J, Christiansen D, Lau C, Mathisen M
Clin Exp Immunol. 2018; 196(1):97-110.
PMID: 30444525
PMC: 6422650.
DOI: 10.1111/cei.13240.
Boenisch M, Hurst R, Huber S, Koehn J, Krapfenbauer K
EPMA J. 2014; 5(1):5.
PMID: 24650571
PMC: 3998108.
DOI: 10.1186/1878-5085-5-5.
Santer D, Hall B, George T, Tangsombatvisit S, Liu C, Arkwright P
J Immunol. 2010; 185(8):4738-49.
PMID: 20844193
PMC: 3065655.
DOI: 10.4049/jimmunol.1001731.
Eison T, Ault B, Jones D, Chesney R, Wyatt R
Pediatr Nephrol. 2010; 26(2):165-80.
PMID: 20652330
DOI: 10.1007/s00467-010-1554-6.
McLean R
Pediatr Nephrol. 1993; 7(2):226-32.
PMID: 8476725
DOI: 10.1007/BF00864413.
Terminal complement complexes in acute poststreptococcal glomerulonephritis.
Matsell D, Wyatt R, Gaber L
Pediatr Nephrol. 1994; 8(6):671-6.
PMID: 7696103
DOI: 10.1007/BF00869086.
Similarities and dissimilarities between the binding ability of C1q and collagen.
Csako G, Suba E, Herp A
Clin Exp Immunol. 1981; 44(1):181-90.
PMID: 7261474
PMC: 1537232.
Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
Adu D, Williams D
Clin Exp Immunol. 1984; 55(3):495-501.
PMID: 6705265
PMC: 1535927.
The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis.
Morrow W, Williams D, Ferec C, Casburn-Budd R, Isenberg D, Paice E
Ann Rheum Dis. 1983; 42(6):668-71.
PMID: 6606402
PMC: 1001326.
DOI: 10.1136/ard.42.6.668.
Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
Potter B, Brown D, Watson A, Jewell D
Gut. 1980; 21(12):1030-4.
PMID: 6450718
PMC: 1419393.
DOI: 10.1136/gut.21.12.1030.
Complement in overt and asymptomatic nephritis after skin infection.
Derrick C, Reeves M, DILLON Jr H
J Clin Invest. 1970; 49(6):1178-87.
PMID: 5422020
PMC: 322584.
DOI: 10.1172/JCI106332.
Metabolism of human C1q. Studies in hypogammaglobulinemia, myeloma, and systemic lupus erythematosus.
Kohler P, MULLER-EBERHARD H
J Clin Invest. 1972; 51(4):868-75.
PMID: 5014614
PMC: 302200.
DOI: 10.1172/JCI106881.
IgG3 levels in patients with chronic membranoproliferative glomerulonephritis.
Thompson R
Br Med J. 1972; 1(5795):282-4.
PMID: 5008479
PMC: 1787169.
DOI: 10.1136/bmj.1.5795.282.
Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus.
Koffler D, Agnello V, Kimkel H
Am J Pathol. 1974; 74(1):109-24.
PMID: 4809310
PMC: 1910734.
Serum complement in chronic liver disease.
Potter B, Trueman A, Jones E
Gut. 1973; 14(6):451-6.
PMID: 4737028
PMC: 1412744.
DOI: 10.1136/gut.14.6.451.
Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.
McLean R, Michael A
J Clin Invest. 1973; 52(3):634-44.
PMID: 4630981
PMC: 302302.
DOI: 10.1172/JCI107225.
Serum complement after orthotopic transplantation of the human liver.
Torisu M, Yokoyama T, Kohler P, Durst A, Martineau G, SCHROTER G
Clin Exp Immunol. 1972; 12(1):21-30.
PMID: 4628404
PMC: 1553651.
C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.
Thompson R
Immunology. 1972; 22(1):147-58.
PMID: 4622449
PMC: 1408205.
Complement and the kidney.
PETERS D, Williams D
Proc R Soc Med. 1972; 65(12):1095-8.
PMID: 4568538
PMC: 1644458.
The significance of C3 and C4 complement levels in lupus nephritis.
Levo Y, Pick A
Int Urol Nephrol. 1974; 6(3-4):233-8.
PMID: 4549215
DOI: 10.1007/BF02089270.